ACETO to Participate at Upcoming Investor Conferences in January

PORT WASHINGTON, N.Y., Dec. 20, 2016 -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that management will participate in two investor conferences.

• CJS Securities "New Ideas for the New Year" Investor Conference on Wednesday, January 11, 2017 in New York City, NY.  Douglas Roth, Senior Vice President and CFO, will provide an overview of the company, discuss its competitive position and its strategies for growth and will hold one-on-one meetings at the conference throughout the day.
   
• 35^th Annual J.P. Morgan Healthcare Conference on Thursday, January 12, 2017 in San Francisco, California.   Salvatore Guccione, President and CEO, is scheduled to present at 11:30 AM PT / 2:30 PM ET and will hold one-on-one meetings at the conference.

Investors will be able to download management’s PowerPoint presentations under Events and Presentations in the investor relations section of the company’s website at www.aceto.com.

ABOUT ACETO

ACETO Corporation, incorporated in 1947 and with offices and operations in 10 countries, is engaged in the development, marketing, sale and distribution of Human Health products (finished dosage form generics and nutraceuticals), Pharmaceutical Ingredients (pharmaceutical intermediates and active pharmaceutical ingredients) and Performance Chemicals (specialty chemicals and agricultural protection products).

Investor Relations Contact
LHA
Jody Burfening
[email protected]
(212) 838-3777